Skip to main content
Premium Trial:

Request an Annual Quote

Gates Foundation Awards Somalogic Additional Funding for Tuberculosis Biomarker Work

Premium

NEW YORK (GenomeWeb News) – Somalogic said this week that it has received additional funding from the Bill & Melinda Gates Foundation for the development and validation of tuberculosis biomarker assays based on its Somamer technology.

The funding expands upon an initial grant awarded in 2012 by the foundation to Somalogic for work on assays that detect TB proteins and monitor infection-related changes to host proteins.

With the new funding, Somalogic researchers will evaluate the feasibility of a rapid TB diagnostic based on these assays, as well as investigate the diagnostic's performance in sample types such as serum, plasma, and urine.

The Gates Foundation's support "will help us accelerate the realization of our shared goal of defining a low-cost, simple to use tool that can quickly and accurately diagnose TB in developing countries," Urs Ochsner, head of Somalogic's infectious diseases research group, said in a statement.

Financial details of the supplemental grant were not disclosed.

The Scan

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.

Adenine Base Editor Targets SCID Mutation in New Study

Researchers from the University of California, Los Angeles, report in Cell that adenine base editing was able to produce functional T lymphocytes in a model of severe combined immune deficiency.

Researchers Find Gene Affecting Alkaline Sensitivity in Plants

Researchers from the Chinese Academy of Science have found a locus affecting alkaline-salinity sensitivity, which could aid in efforts to improve crop productivity, as they report in Science.

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.